rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AUTL
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Autolus Therapeutics PLC (AUTL) (Q3 2026) Earnings Call Highlights: AUCATZYL Revenue Nearly ...
      Nov 10Yahoo FinanceAUTL
      Autolus reports longer-term data for lupus cell therapy trial
      Nov 10Investing.comAUTL
      Autolus Therapeutics Q3 Earnings Call Highlights
      Nov 10Yahoo FinanceAUTL
      Autolus Therapeutics Q3 2026 Earnings Call Transcript
      Nov 10BenzingaAUTL
      Autolus Therapeutics earnings missed by $0.05, revenue topped estimates
      Nov 10Investing.comAUTL
      H.C. Wainwright initiates Autolus stock coverage with buy rating
      Nov 2Investing.comAUTL
      Autolus Therapeutics: Cheap On Sales, Still Far From Breakeven (NASDAQ:AUTL)
      Oct 27Seeking AlphaAUTL
      Autolus Stock: Key Questions For The Near Term (NASDAQ:AUTL)

      Autolus Therapeutics looks undervalued as revenue grows and autoimmune catalysts near. Read here for a detailed analysis of AUTL stock.

      Oct 27Seeking AlphaAUTL
      All You Need to Know About Autolus Therapeutics (AUTL) Rating Upgrade to Buy

      Autolus Therapeutics (AUTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

      Oct 5Yahoo FinanceAUTL
      Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT)

      Detailed price information for Rocket Pharmaceuticals Inc (RCKT-Q) from The Globe and Mail including charting and trades.

      Oct 3The Globe and MailAUTL
      H.C. Wainwright Keeps Their Buy Rating on Autolus Therapeutics (AUTL)

      Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailAUTL
      AUCATZYL Sales Are Exploding, But Autolus (AUTL) Still Isn’t In The Black

      On August 11, Autolus Therapeutics (NASDAQ:AUTL) reported second-quarter results that finally showed the kind of growth investors had been waiting years to see. Net product revenue hit $45.7 million, up 119% from $20.9 million a year earlier and up from $26.2 million just one quarter prior. Management used the momentum to raise full-year 2026 guidance […]

      Sep 12Yahoo FinanceAUTL
      Wall Street Analysts Are Bullish on Top Healthcare Picks

      Detailed price information for Stryker Corp (SYK-N) from The Globe and Mail including charting and trades.

      Sep 10The Globe and MailAUTL
      Autolus receives FDA regenerative medicine designation for obe-cel
      Sep 9Investing.comAUTL
      Autolus Receives FDA Regenerative Medicine Advanced Therapy Designation for Obecabtagene Autoleucel

      Autolus Therapeutics (AUTL) said Wednesday that the US Food and Drug Administration has granted rege

      Sep 9Yahoo FinanceAUTL
      Autolus Therapeutics Earnings Call Highlights Growth Momentum

      Tipranks Press Release.

      Aug 24The Globe and MailAUTL
      Autolus Therapeutics Earnings Call Highlights Growth Momentum

      Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

      Aug 23The Globe and MailAUTL

      This is the newest page. Registered accounts read further back.